News | June 20, 2022
Aurobindo Pharma board approves acquisition of GLS Pharma
The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.
The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
The unit is an oral manufacturing facility at Jedcherla, Hyderabad
A centralised kitchen which provides 5,000 breakfast meals per day is to be started at Perumallapuram, Kakinada, Andhra Pradesh
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
CuraTeQ and Orion had entered into a licensing agreement, granting marketing and distribution rights for CuraTeQ’s biosimilar products under development in the Nordic states, Austria, Hungary and Slovenia
The brand is now available pan-India through their distribution partner
The drug will be marketed under the brand name Molnaflu
Subscribe To Our Newsletter & Stay Updated
